{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T02:55:07Z","timestamp":1789786507287,"version":"4.0.1"},"reference-count":26,"publisher":"Japanese Association for Laboratory Animal Science","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp. Anim."],"published-print":{"date-parts":[[2015]]},"DOI":"10.1538\/expanim.14-0111","type":"journal-article","created":{"date-parts":[[2015,4,23]],"date-time":"2015-04-23T22:23:51Z","timestamp":1429827831000},"page":"295-303","source":"Crossref","is-referenced-by-count":59,"title":["An &lt;i&gt;in vivo&lt;\/i&gt; mouse model of primary dysmenorrhea"],"prefix":"10.1538","volume":"64","author":[{"given":"Lu","family":"YANG","sequence":"first","affiliation":[{"name":"Department of Complex Prescription of TCM, China Pharmaceutical University, Nanjing, Jiangsu, P.R.China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengyu","family":"CAO","sequence":"additional","affiliation":[{"name":"Department of Complex Prescription of TCM, China Pharmaceutical University, Nanjing, Jiangsu, P.R.China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyang","family":"YU","sequence":"additional","affiliation":[{"name":"Department of Complex Prescription of TCM, China Pharmaceutical University, Nanjing, Jiangsu, P.R.China"},{"name":"Jiangsu Provincial Key Laboratory for TCM Evaluation and Translational Research, China Pharmaceutical University, Nanjing, Jiangsu, P.R.China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengzhi","family":"CHAI","sequence":"additional","affiliation":[{"name":"Department of Complex Prescription of TCM, China Pharmaceutical University, Nanjing, Jiangsu, P.R.China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"439","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Aguilar H.N. and Mitchell, B.F. 2010. Physiological pathways and molecular mechanisms regulating uterine contractility. <i>Hum. Reprod. Update.<\/i> 16: 725\u2013744.","DOI":"10.1093\/humupd\/dmq016"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Akerlund M. 1979. Pathophysiology of dysmenorrhea. <i>Acta Obstet. Gynecol. Scand. Suppl.<\/i> 87: 27\u201332.","DOI":"10.3109\/00016347909157786"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Akerlund M. 2006. Targeting the oxytocin receptor to relax the myometrium. <i>Expert Opin. Ther. Targets<\/i> 10: 423\u2013427.","DOI":"10.1517\/14728222.10.3.423"},{"key":"4","unstructured":"4. Altunyurt S., G\u00f6l M., Altunyurt S., Sezer O., and Demir N. 2005. Primary dysmenorrhea and uterine blood flow: a color Doppler study. <i>J. Reprod. Med.<\/i> 50: 251\u2013255."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Caufriez A. 1991. Menstrual disorders in adolescence: pathophysiology and treatment. <i>Horm. Res.<\/i> 36: 156\u2013159.","DOI":"10.1159\/000182151"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Cella M., Aisemberg J., Sordelli M.S., Billi S., Farina M., Franchi A.M., and Ribeiro M.L. 2006. Prostaglandins modulate nitric oxide synthase activity early in time in the uterus of estrogenized rat challenged with lipopolysaccharide. <i>Eur. J. Pharmacol.<\/i> 534: 218\u2013226.","DOI":"10.1016\/j.ejphar.2006.01.019"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Chan W.Y. and Hill J.C. 1978. Determination of menstrual prostaglandin levels in non-dysmenorrheic and dysmenorrheic subjects. <i>Prostaglandins<\/i> 15: 365\u2013375.","DOI":"10.1016\/0090-6980(78)90176-4"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Chen L., Sooranna S.R., Lei K., Kandola M., Bennett P.R., Liang Z., Grammatopoulos D., and Johnson M.R. 2012. Cyclic AMP increases COX-2 expression via mitogen-activated kinase in human myometrial cells. <i>J. Cell. Mol. Med.<\/i> 16: 1447\u20131460.","DOI":"10.1111\/j.1582-4934.2011.01413.x"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Dawood M.Y. and Khan-Dawood F.S. 2007. Clinical efficacy and differential inhibition of menstrual fluid prostaglandin F2alpha in a randomized, double-blind, crossover treatment with placebo, acetaminophen, and ibuprofen in primary dysmenorrhea. <i>Am. J. Obstet. Gynecol.<\/i> 196: 35.e1\u201335.e5.","DOI":"10.1016\/j.ajog.2006.06.091"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Dawood M.Y. 2006. Primary dysmenorrhea: advances in pathogenesis and management. <i>Obstet. Gynecol.<\/i> 108: 428\u2013441.","DOI":"10.1097\/01.AOG.0000230214.26638.0c"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Deligeoroglou E. and Creatsas G. 2012. Menstrual disorders. <i>Endocr. Dev.<\/i> 22: 160\u2013170.","DOI":"10.1159\/000331697"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Dodge K.L. and Sanborn B.M. 1998. Evidence for inhibition by protein kinase A of receptor\/G alpha(q)\/phospholipase C (PLC) coupling by a mechanism not involving PLCbeta2. <i>Endocrinology<\/i> 139: 2265\u20132271.","DOI":"10.1210\/endo.139.5.5963"},{"key":"13","unstructured":"13. French L. 2005. Dysmenorrhea. <i>Am. Fam. Physician<\/i> 71: 285\u2013291."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Fuchs A.R., Ivell R., Ganz N., Fields M.J., and Gimenez T. 2001. Secretion of oxytocin in pregnant and parturient cows: corpus luteum may contribute to plasma oxytocin at term. <i>Biol. Reprod.<\/i> 65: 1135\u20131141.","DOI":"10.1095\/biolreprod65.4.1135"},{"key":"15","unstructured":"15. Hua Y., Duan J.A., Zhu Q., and Wang Q.J. 2008. Study on method of oxytocin induced in vitro dysmenorrhea model in mouse. <i>Chin. Pharmacol. Bull.<\/i> 24: 489\u2013493."},{"key":"16","unstructured":"16. Hu Y.L., Lin Q., Li Y., and Zheng X.H. 2011. [Effect on PGF2alpha in plasma in primary dysmenorrhea treated with eye acupuncture]. <i>Zhongguo Zhenjiu<\/i> 31: 683\u2013686."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Kataoka M., Togashi K., Kido A., Nakai A., Fujiwara T., Koyama T., and Fujii S. 2005. Dysmenorrhea: evaluation with cine-mode-display MR imaging\u2014initial experience. <i>Radiology<\/i> 235: 124\u2013131.","DOI":"10.1148\/radiol.2351031283"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Ostad S.N., Soodi M., Shariffzadeh M., Khorshidi N., and Marzban H. 2001. The effect of fennel essential oil on uterine contraction as a model for dysmenorrhea, pharmacology and toxicology study. <i>J. Ethnopharmacol.<\/i> 76: 299\u2013304.","DOI":"10.1016\/S0378-8741(01)00249-5"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Pirhonen J. and Pulkkinen M. 1995. The effect of nimesulide and naproxen on the uterine and ovarian arterial blood flow velocity. A Doppler study. <i>Acta Obstet. Gynecol. Scand.<\/i> 74: 549\u2013553.","DOI":"10.3109\/00016349509024388"},{"key":"20","unstructured":"20. Shiels I.A. and Whitehouse M.W. 2000. Lyprinol: anti-inflammatory and uterine-relaxant activities in rats, with special reference to a model for dysmenorrhoea. <i>Allerg. Immunol. (Paris)<\/i> 32: 279\u2013283."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Siemieniuch M.J., Woclawek-Potocka I., Deptula K., Okuda K., and Skarzynski D.J. 2009. Effects of tumor necrosis factor-alpha and nitric oxide on prostaglandins secretion by the bovine oviduct differ in the isthmus and ampulla and depend on the phase of the estrous cycle. <i>Exp. Biol. Med. (Maywood)<\/i> 234: 1056\u20131066.","DOI":"10.3181\/0901-RM-23"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Sordelli M.S., Beltrame J.S., Cella M., Franchi A.M., and Ribeiro M.L. 2012. Cyclooxygenase-2 prostaglandins mediate anandamide-inhibitory action on nitric oxide synthase activity in the receptive rat uterus. <i>Eur. J. Pharmacol.<\/i> 685: 174\u2013179.","DOI":"10.1016\/j.ejphar.2012.04.034"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Viero C., Shibuya I., Kitamura N., Verkhratsky A., Fujihara H., Katoh A., Ueta Y., Zingg H.H., Chvatal A., Sykova E., and Dayanithi G. 2010. Oxytocin: Crossing the bridge between basic science and pharmacotherapy. <i>CNS Neurosci. Ther.<\/i> 16: e138\u2013e156.","DOI":"10.1111\/j.1755-5949.2010.00185.x"},{"key":"24","unstructured":"24. Visner S.L. and Blake R.L. Jr. 1985. Physician\u2019s knowledge and treatment of primary dysmenorrhea. <i>J. Fam. Pract.<\/i> 21: 462\u2013466."},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Wouters E., Hudson C.A., McArdle C.A., and Bernal A.L. 2014. Central role for protein kinase C in oxytocin and epidermal growth factor stimulated cyclooxygenase 2 expression in human myometrial cells. <i>BMC Res. Notes<\/i> 7: 357.","DOI":"10.1186\/1756-0500-7-357"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Wrzal P.K., Goupil E., Laporte S.A., H\u00e9bert T.E., and Zingg H.H. 2012. Functional interactions between the oxytocin receptor and the \u03b22-adrenergic receptor: implications for ERK1\/2 activation in human myometrial cells. <i>Cell. Signal.<\/i> 24: 333\u2013341.","DOI":"10.1016\/j.cellsig.2011.09.019"}],"container-title":["Experimental Animals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/expanim\/64\/3\/64_14-0111\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,24]],"date-time":"2019-08-24T01:19:45Z","timestamp":1566609585000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/expanim\/64\/3\/64_14-0111\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1538\/expanim.14-0111","relation":{},"ISSN":["1341-1357","1881-7122"],"issn-type":[{"value":"1341-1357","type":"print"},{"value":"1881-7122","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}